A systematic review and economic evaluation of adalimumab and dexamethasone for treating non-infectious intermediate uveitis, posterior uveitis or panuveitis in adults. [electronic resource]
Producer: 20180725Description: 1-170 p. digitalISSN:- 2046-4924
- Adalimumab -- therapeutic use
- Adult
- Anti-Inflammatory Agents -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Cost-Benefit Analysis
- Dexamethasone -- therapeutic use
- Humans
- Quality-Adjusted Life Years
- Technology Assessment, Biomedical
- Uveitis, Intermediate -- drug therapy
- Uveitis, Posterior -- drug therapy
No physical items for this record
Publication Type: Journal Article; Meta-Analysis; Review; Systematic Review
There are no comments on this title.
Log in to your account to post a comment.